Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics

John G. Csernansky*, Catherine T. Wrona, Mark E. Bardgett, Terrance S. Early, John W. Newcomer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

The effects of acute (1 day) and subchronic (28 days) treatment with three atypical antipsychotic drugs [clozapine, (±)-sulpiride and (-)-3-PPP] on dopamine and serotonin turnover in both the nucleus accumbens (NA) and corpus striatum (CS) of rodents was compared to haloperidol and saline treatment. The equivalent doses of all drugs were determined based upon their ability to compete in vivo for3H-spiperone binding in the NA and CS. All three atypical drugs, compared to haloperidol, produced preferential elevations of dopamine turnover in the NA. Further, the development of tolerance to this effect was more apparent for the three atypical drugs than for haloperidol. Surprisingly, all three atypical drugs, but not haloperidol, produced changes in serotonin turnover, despite the fact that (±)-sulpiride and (-)-3-PPP have no known direct effects on brain serotonin systems. All three atypical drugs produced acute increases in serotonin turnover in both the NA and CS, followed by later decreases.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalPsychopharmacology
Volume110
Issue number1-2
DOIs
StatePublished - Jan 1 1993

Keywords

  • 3-PPP
  • Clozapine
  • Dopamine
  • Haloperidol
  • Neuroleptics
  • Serotonin
  • Sulpiride

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics'. Together they form a unique fingerprint.

Cite this